Summary The purpose of this study was to define a correlation between telomerase actvity and human papillomavirus (HPV) 
was thouaht to be activated specifically in malignant but not in most normal tissues (Kim et al. 1994) . Furthermore. studies of telomerase activity in premalignant lesions help define howi telomerase is associated with multistep carcinogenesis and. if detectable. the telomerase assay can be applied for early detection of cancer (Mutirangura et al. 1996: Shav and Gardar 1997) .
Specific histological classifications differentiate cerxical premalignant and malignant lesions as loby-gfrade and high-grade squamous intraepithelial lesions (SILs) and invasive carcinoma (Lundberg. 1989) . Recent studies demonstrated a higher frequency of telomerase actixitv in cervical cancer (88-100%c) than SILs (25-59%7) (Anderson et al. 1997 : Kyo et al. 1997 : Pao et al. 1997 : Zheng et al. 1997 ). In addition. this higher frequency of telomerase expression w-as discovered in both HPV-positive and -neaative cervical cancers (Anderson et al. 1997 (Freshney 1987 Positive assays were reconfirmed with and without RNAase pretreatment with newlxl described primers (Kim et al. 1997 After 10 min incubation at 23-C to allow telomerase-mediated extension of the TS primer. the reaction mixture was subjected to 30 PCR cNcles at 94C for 1 min. 50fC for 1 mmn and 72C for 1 mmn. Aliquots (5 jl) of the PCR products were anal-sed on an 8%7c non-denaturin, polvacrylamide gel. The gel wxas subsequently exposed to a phosphor screen and the bands were visualized on a Phosphorimager using Image Quant softw are (Molecular Dxnamics. Sunnyvale. CA. USA).
HPV PCR
Pellets derixed from the prexvious extraction with CHAPS l-sis buffer were subjected to standard DNA extraction (NManiatis et al. 1989 ). The DNA xxas used for subsequent HPV PCR. Control HPV DNA used in the amplification was obtained from Hela cell lines.
LI and E6 amplification were performed as previously described (Resnick et al. 1990 : Bauer et al. 1991 Telormerase actvity and HPV in cenrcal ksions 937 NaOH). The membranes were transferred to a filter paper soaked in neutralizing solution (1.5 M NaCl. 0. (Table 2 ). The dosage of telomerase activity was then recorded as <100, 100-1000. or >1000, indicating whether the intensity of those bands was less than 100, or between 100 and 1000 or more than 1000 B958 cells respectively. The variation in expression of telomerase has been detected in all types of cervical lesions. Nevertheless, in general the invasive cancers expressed the highest telomerase activity and the benign lesions and normal cervical tissues expressed the lowest. This comparison was valid in both HPV-positive and -negative groups.
In order to identify whether telomerase expression originated from epithelium or activated lymphocytes in connective tissue. collagenase treatment was applied to some SILs and benign lesions. In the case of most lesions. a higher level of telomerase activity was detected in epithelial tissues. In addition. there were four cases of SILs and one case of cervicitis where we could ascribe the telomerase activity exclusively to the epithelium. Hence. detectable telomerase activity should be located within the epithelial layer of the cervix (Figure 3) As for benign cervical lesions. no significant correlation of telomerase activity with the HPV status (p>0.5) became apparent.
Whereas 20% of HPV-positive cases exhibited telomerase activity, 52% of the HPV-negative group were telomerase positive in the TRAP assay. This may imply that HPV infection does not lead to telomerase activation in benign cervical lesions (Table 2) .
DISCUSSION
Telomerase is a ribonucleoprotein enzyme that synthesizes telomeres, the specialized structures containing unique simple repetitive sequences (TTAGGG in vertebrates) at the end of chromosomes (Blackburn 1991 : Feng et al, 1995 . The enzyme activity provides the means to compensate for the end replication problem and thus expression of telomerase might be a crucial factor allowing cells to proliferate indefinitely (Counter et al. 1992) . Once thought to be cancer-cell specific, it is becoming apparent that many proliferating normal cells express telomerase activity at a lower level.
Among these are human activated lymphocytes and several types of epithelium (Taylor et al, 1996; Yasumoto et al, 1996 : Engelhardt et al. 1997 . This study performed on the cervix demonstrated similar findings. A low level of telomerase activity was detectable in nornal cervical tissues and benign lesions and may be necessary for their physiological proliferation. On the other hand, the pattern of telomerase expression in SILs and carcinoma cases indicates that telomerase is involved during cancer development and activated during the late stage of multistep carcinogenesis.
In order to identify whether and how HPV is associated with telomerase activity, several cervical samples were tested by means of TRAP assay and HPV DNA detection using LI and E6 primers. One of the most crucial parts played by HPV in cervical carcinogenesis is activation of telomerase. It will be interesting to explore whether HPV infection alone or additional genetic alterations are required for telomerase activation during cervical carcinogenesis. Several studies performed on the transforming activity of HPV have shown the capability of high-risk HPV E6 to transform cells to the immortalized state. One study on human keratinocyte retrovirus-mediated transduction found that the E6 protein alone was sufficient for early telomerase activation (Klingelhutz et al 1996; Stoppler et al 1997) . However, another study on human keratinocytes transfected with full-length, highrisk HPV has shown additional genetic events to be required for increased levels of telomerase expression (Steenbergen et al, 1996) . Our data showed that 50%, 80% and 95% of HPV-positive SILs, MIC and squamous-cell cancer expressed telomerase respectively. This provided evidence that the transforming activity of high-risk-type HPV did not encompass telomerase activation at the initiation of cervical carcinogenesis, but might be triggered by subsequent genetic aberrations at some later stage.
Previous studies demonstrated that telomerase activity was detectable in cervical scrapings, suggesting that the TRAP assay is a useful screening method for cervical lesions, especially when combined with a Pap smear test (Kyo et al 1997) . However, our results demonstrated that more than 40% of benign lesions and nornal cervical tissues were positive in the TRAP assay. regardless of their HPV status. This may limit the usefulness of this application. Nevertheless, as a very high frequency of telomerase expression was observed in the early invasive lesions, this enzyme activity may constitute a biomarker regarding malignant transformation or invasiveness. It may be worth pursuing the clinical usefulness of this molecular marker in the future.
